AllianceLifeSciences

Alliance Life Sciences is now EVERSANA.

[AllianceLifeSciences @ALSCG]

Thank you for following Alliance these past 8 years! Alliance Life Sciences is now EVERSANA. Please connect with us and visit us at https://t.co/gGPVCCXFIh for more information.

[AllianceLifeSciences @ALSCG]

IRP FOR MEDICARE? Drastic change to US policy means new mitigation strategies for pharma. https://t.co/U3EU00Fz1B

[AllianceLifeSciences @ALSCG]

Anita Burrell, Alan Crowther, Alfonso Garbayo, MBA, and David Rees will be representing @EVERSANAcompany at ISPOR EUROPE 2018 in Barcelona. Send a direct message to arrange a meeting with our experts.

[AllianceLifeSciences @ALSCG]

Master Your Product Master: Line Extensions, Designations, Considerations, and Implications @MDRP Digital Week Tue 11/6 1pmEST https://t.co/SXvx6LoWUy

[AllianceLifeSciences @ALSCG]

Master Management is still a complicated process. MDRP Digital week will cover this topic: Master Your Product Master: Line Extensions, Designations, Considerations, and Implications Tuesday, November 06, 2018, 1:00pm EST - Register for MDRP Digital Week https://t.co/p4fQLfUVy4

[AllianceLifeSciences @ALSCG]

FDA Approves Revcovi™, a New Enzyme Replacement Therapy Developed by Leadiant Biosciences, for the Treatment of ADA-SCID in Pediatric and Adult Patients https://t.co/FOvHQmi40w

[AllianceLifeSciences @ALSCG]

Introducing team EVERSANA to our Global Pricing clients & sharing our mission to advance life science towards a healthier world.
#PriceRight #Pricentric #globalpricing #weareeversana Follow us @eversanacompany

[AllianceLifeSciences @ALSCG]

Life Sciences Pricing Forum is now on! Visit the EVERSANA Booth to learn more about our mission to advance life science towards a healthier world and our dedication to Global Pricing, Market Access & HEOR. Follow us @eversanacompany
https://t.co/qpHJ4A58TP

[AllianceLifeSciences @ALSCG]

Our Global Pricing Team is excited to welcome our user group in Switzerland. What’s on the agenda? Latest updates on products and learning more how mobile is changing the global pricing experience. #PriceRight #Pricentric #globalpricing #weareeversana Follow us @eversanacompany

[AllianceLifeSciences @ALSCG]

Sneak peek into our user group meeting room. Clients will be surprised to see their new EVERSANA goodies awaiting. If you are in Montreux for the EPP conference, stop by to meet our Global Pricing, EVERSANA team. #weareeversana Follow us @eversanacompany

[AllianceLifeSciences @ALSCG]

Global Life Science Services Platform Unites Under New Name, EVERSANA™ https://t.co/4M9oVFC6NW

[AllianceLifeSciences @ALSCG]

Check out the inspiration behind @EVERSANAcompany and our vision to advance life science services for a healthier world. hashtag#weareeversana
https://t.co/lAu0B2gnGg

[AllianceLifeSciences @ALSCG]

Today we launched the new name & brand of our integrated life science services platform, EVERSANA. Check out the meaning and inspiration!
https://t.co/lAu0B2gnGg

[AllianceLifeSciences @ALSCG]

Parallel importers purchase drugs in low-cost markets such as France, Greece, and Spain, and then transport, repackage, and resell the drugs in more lucrative markets such as Germany or the UK, where demand yields higher prices as well as quick profits. https://t.co/3YJCXphlbp

[AllianceLifeSciences @ALSCG]

Regardless of initial uncertainty over competition and uptake due to the varied #regulatory processes across the #EU, #biosimilar uptake has taken off and is continuing to grow. https://t.co/72A4Y1tbms

[AllianceLifeSciences @ALSCG]

New article published by @worldpharma2day magazine examines the worldwide uptake and pricing of #Biosimilar #drugs. It features pricing data by @PricentricALSCG https://t.co/72A4Y1tbms

[AllianceLifeSciences @ALSCG]

To adequately prepare for the Medicare Part D changes in 2019, pharmaceutical companies with Part D eligible drugs should review their business model, market approach, and pricing strategy around any applicable products. https://t.co/DlSXp7xfYk

[The PEP @ThePatientExp]

As countries around the world tackle the challenges of #healthcare, news like this is welcomed. Read how New Zealand is taking steps to improve access to rare disease treatments.

https://t.co/Jc5SQwszWg

[AllianceLifeSciences @ALSCG]

Signed into law on February 9, 2018, the Bipartisan Budget Act #BBA of 2018 entails significant adjustments to consumer spending under the @Medicare #PartD #prescription drug program. https://t.co/DlSXp7xfYk

[PRICENTRIC @PricentricALSCG]

Roche’s Tecentriq in combination with Avastin gets breakthrough therapy designation by FDA. #livercancer
https://t.co/C39JjZyEEr